# Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan

> **NCT05750043** · — · COMPLETED · sponsor: **Universiteit Antwerpen** · enrollment: 17000 (actual)

## Conditions studied

- Onchocerciasis
- Epilepsy

## Interventions

- **DRUG:** bi-annual CDTI

## Key facts

- **NCT ID:** NCT05750043
- **Lead sponsor:** Universiteit Antwerpen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2023-01-31
- **Final completion:** 2023-02-19
- **Target enrollment:** 17000 (ACTUAL)
- **Last updated:** 2023-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05750043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05750043, "Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05750043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*